rxstat › Prices in Saskatchewan › Evolocumab

Evolocumab (Repatha) price and coverage in Saskatchewan

Evolocumab 140 mg/ml solution lists at $291.67 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Evolocumab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.

Provinces bill this product in different units (per mL, per pen or per vial), so their prices are not directly comparable.

Price by strength in Saskatchewan

Strength and formLowest priceBrand
140 mg/ml Solution1 product · special approval$291.67/unit–
All 1 products listed in Saskatchewan
ProductPriceCoverage
140 mg/ml Solution
RepathaAMG · DIN 02446057$291.67/unitSpecial approval

What you'll pay at the pharmacy

These are the prices the Saskatchewan Drug Plan lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.

Shortage status

No active shortage is reported for Evolocumab in Canada. Full drug page.

Evolocumab price in other provinces

Common questions

How much does Evolocumab cost in Saskatchewan?

Evolocumab 140 mg/ml solution lists at $291.67 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Is Evolocumab covered in Saskatchewan?

Evolocumab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.

Is Evolocumab cheaper in another province?

For 140 mg/ml solution, listed prices run from $291.67 to $291.67 across 4 provinces. Public plans only cover their own residents, though.

Source: Saskatchewan Drug Plan Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.